Internal Medicine, Hematology & Oncology · Corpus Christi, TX
NPI
1144209024
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1625 Rodd Field Rd, Suite 100
Corpus Christi, TX, 78412
Phone (361) 887-0067
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
202,162 services
Medicare patients, 2024
319
Average age 74
Drug cost, 2024
$7.9M
2,827 prescriptions
Company payments, 2025
$5,152
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emile C Salloum was code J9267 (injection, paclitaxel, 1 mg), 15,840 times for 11 patients. In total Emile C Salloum billed 202,162 services in 106 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9267 Injection, paclitaxel, 1 mg | Office | 15,840 | 11 | $0.08 | $1,269 |
| J9073 Injection, cyclophosphamide (ingenus), 5 mg | Office | 8,849 | 11 | $0.70 | $6,227 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 5,938 | 56 | $0.09 | $519 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 4,668 | 47 | $0.07 | $342 |
| J0897 Injection, denosumab, 1 mg | Office | 3,600 | 17 | $20.46 | $74K |
| 96367 Intravenous Infusion, Hydration | Office | 837 | 61 | $20.52 | $17K |
| 96413 Chemotherapy Administration | Office | 612 | 68 | $90.72 | $56K |
| 99214 Office E&M - Established | Office | 436 | 209 | $87.84 | $38K |
| J9000 Injection, doxorubicin hydrochloride, 10 mg | Office | 328 | 11 | $2.62 | $860 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 263 | 36 | $0.63 | $166 |
| 96372 Injection Administration | Office | 248 | 43 | $10.38 | $2,573 |
| 96415 Chemotherapy Administration | Office | 216 | 36 | $19.62 | $4,239 |
| 96401 Chemotherapy Administration | Office | 191 | 21 | $50.39 | $9,624 |
| 96417 Chemotherapy Administration | Office | 177 | 32 | $44.87 | $7,942 |
| 99213 Office E&M - Established | Office | 173 | 106 | $64.83 | $11K |
By year: 2022 $3.2M for 131,295 services; 2023 $3.5M for 185,828 services; 2024 $3.0M for 202,162 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emile C Salloum prescribed most often to Medicare patients was Anastrozole, with 569 prescriptions and refills. In total Emile C Salloum wrote 2,827 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 569 | 1,017 | 125 | $6,152 |
| Tamoxifen Citrate Generic | 286 | 532 | 58 | $5,610 |
| Letrozole Generic | 201 | 339 | 44 | $3,526 |
| Ondansetron Hcl Generic | 131 | 131 | 92 | $915 |
| Prochlorperazine Maleate Generic | 107 | 109 | 72 | $1,868 |
| Valacyclovir Valacyclovir Hcl | 104 | 166 | 27 | $3,864 |
| Udenyca Pegfilgrastim-Cbqv | 86 | 86 | 26 | $350K |
| Dexamethasone Generic | 85 | 98 | 46 | $1,023 |
| Lenalidomide Generic | 80 | 80 | 11 | $946K |
| Gabapentin Generic | 69 | 83 | 21 | $611 |
| Levothyroxine Sodium Generic | 54 | 63 | Under 11 | $162 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 54 | 54 | 48 | $632 |
| Pantoprazole Sodium Generic | 53 | 101 | 14 | $406 |
| Prednisone Generic | 46 | 46 | 12 | $153 |
| Cabometyx Cabozantinib S-Malate | 42 | 42 | Under 11 | $957K |
Brand drugs: 644 claims; generic drugs: 2,183 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emile C Salloum $5,152 ($5,152 in general payments such as food, travel and fees) from 40 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $524.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $524 |
| Janssen Biotech, Inc. JNJ | 20 | $484 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $410 |
| Merck Sharp & Dohme LLC MRK | 15 | $326 |
| Pfizer Inc. PFE | 15 | $275 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $266 |
| Celgene Corporation BMY | 10 | $198 |
| PharmaEssentia USA Corporation 6446.TW | 4 | $196 |
| Incyte Corporation INCY | 8 | $164 |
| Gilead Sciences, Inc. GILD | 7 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.